Representation of the 606 neurological patients in the clinical groups.
- Marta Molero-Luis (499096)
- Sergio Fernández-Ureña (499097)
- Iolanda Jordán (499098)
- Mercedes Serrano (499099)
- Aida Ormazábal (435124)
- Àngels Garcia-Cazorla (3165906)
- Rafael Artuch (435125)
Publication date
December 2013
DOIAbstract
<p>Each group shows the percentage of patients with high CSF WBC, high CSF proteins and high CSF neopterin. The inflammatory/immune-mediated group had a significantly elevated percentage of high CSF WBC (<sup>*</sup>X<sup>2</sup> = 27.91, p<0.001), high CSF proteins (<sup>Ψ</sup>X<sup>2</sup> = 17.51, p<0.001) and high CSF NP (<sup>Φ</sup>X<sup>2</sup> = 103.73, p<0.001) compared with the other groups.</p
Add to ORKG